Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D. Johnson Holdings is a private investment firm primarily focused on the life sciences and biotechnology sectors. Founded and led by David Johnson, a veteran biotech executive known for his leadership at VelosBio and GigaGen, the firm provides strategic capital and advisory services to emerging healthcare companies. The organization leverages its deep industry expertise to identify and support innovative therapeutic platforms and drug development programs. D. Johnson Holdings operates as a family office and investment vehicle, participating in various funding rounds for high-growth biotech startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DJohnson Holdings.